With austerity abandoned by all major economies, a global spending surge may turbo-charge oil demand. The vaccine catch-up rally for unloved commodity stocks over the last three weeks may just be the appetizer before the supercycle gets going in earnest.
- by Ambrose Evans-Pritchard
The ASX 200 slipped 0.7% to 6636.4 on Thursday as the November cyclical rally cooled off following a mixed Wall Street session.
- by Alex Druce
Whether you are a professional investor who cashed out at a $US50 million loss or an amateur, Bitcoin's latest rally is a story of what could have been.
- by Anna Irrera
The S&P/ASX 200 is all but back where it started 2020, sitting just 7 per cent below the all-time high it tapped in February, and analysts say a Santa rally could push it higher.
- by Lucy Battersby
There are some fundamentally poor quality shares that are being swept up by enthusiastic investors attempting to play the COVID trade.
- by Elizabeth Knight
The US sharemarket regulator plans to kick Chinese companies from Wall Street unless they allow its inspectors to audit their auditors.
- by Stephen Bartholomeusz
It’s an attention-grabbing psychological threshold, and it’s an encouraging signal that the US market’s rally is broadening beyond the handful of stocks that carried Wall Street through the pandemic.
- by Stan Choe
The S&P/ASX 200 jumped 1% at the open to get above 6700 points for the first time since February. The market closed 0.6% higher and just below where it started 2020.
- by Lucy Battersby and Alex Druce
President Trump congratulates 'everybody' as the Dow Jones breached the 30,000-mark for the first time on optimism that COVID-19 vaccines will open the way to economic recovery next year.
- by Alex Veiga and Damian Troise
Investors continue to snap up its shares in the run-up to its debut in the S&P 500, extending a rally that has seen it surge over 500 per cent this year.
- by Subrat Patnaik and Noel Randewich